Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Investigation of 15q11-q13, 16p11.2 and 22q13 CNVs in Autism Spectrum Disorder Brazilian Individuals with and without Epilepsy

Full text
Author(s):
Show less -
Moreira, Danielle P. [1] ; Griesi-Oliveira, Karina [1] ; Bossolani-Martins, Ana L. [2] ; Lourenco, Naila C. V. [1] ; Takahashi, Vanessa N. O. [1] ; da Rocha, Katia M. [1] ; Moreira, Eloisa S. [1] ; Vadasz, Estevao [3] ; Castro Meira, Joanna Goes [1] ; Bertola, Debora [4, 1] ; O' Halloran, Eoghan [5] ; Magalhaes, Tiago R. [5, 6] ; Fett-Conte, Agnes C. [2] ; Passos-Bueno, Maria Rita [1]
Total Authors: 14
Affiliation:
[1] Univ Sao Paulo, Inst Biociencias, Ctr Pesquisas Genoma Humano & Celulas Tronco, Dept Genet & Biol Evolut, Sao Paulo - Brazil
[2] Fac Med Sao Jose do Rio Preto, Dept Biol Mol, Sao Jose Do Rio Preto, SP - Brazil
[3] Univ Sao Paulo, Fac Med, Hosp Clin, Inst Psiquiatria, Sao Paulo - Brazil
[4] Univ Sao Paulo, Fac Med, Inst Crianca, Sao Paulo - Brazil
[5] Natl Univ Ireland Univ Coll Dublin, Sch Med & Med Sci, Acad Ctr Rare Dis, Dublin 4 - Ireland
[6] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin - Ireland
Total Affiliations: 6
Document type: Journal article
Source: PLoS One; v. 9, n. 9 SEP 25 2014.
Web of Science Citations: 12
Abstract

Copy number variations (CNVs) are an important cause of ASD and those located at 15q11-q13, 16p11.2 and 22q13 have been reported as the most frequent. These CNVs exhibit variable clinical expressivity and those at 15q11-q13 and 16p11.2 also show incomplete penetrance. In the present work, through multiplex ligation-dependent probe amplification (MLPA) analysis of 531 ethnically admixed ASD-affected Brazilian individuals, we found that the combined prevalence of the 15q11-q13, 16p11.2 and 22q13 CNVs is 2.1% (11/531). Parental origin could be determined in 8 of the affected individuals, and revealed that 4 of the CNVs represent de novo events. Based on CNV prediction analysis from genome-wide SNP arrays, the size of those CNVs ranged from 206 kb to 2.27 Mb and those at 15q11-q13 were limited to the 15q13.3 region. In addition, this analysis also revealed 6 additional CNVs in 5 out of 11 affected individuals. Finally, we observed that the combined prevalence of CNVs at 15q13.3 and 22q13 in ASD-affected individuals with epilepsy (6.4%) was higher than that in ASD-affected individuals without epilepsy (1.3%; p < 0.014). Therefore, our data show that the prevalence of CNVs at 15q13.3, 16p11.2 and 22q13 in Brazilian ASD-affected individuals is comparable to that estimated for ASD-affected individuals of pure or predominant European ancestry. Also, it suggests that the likelihood of a greater number of positive MLPA results might be found for the 15q13.3 and 22q13 regions by prioritizing ASD-affected individuals with epilepsy. (AU)

FAPESP's process: 08/57899-7 - Stem cells in human genetic diseases - CETGEN
Grantee:Mayana Zatz
Support type: Research Projects - Thematic Grants
FAPESP's process: 13/08028-1 - CEGH-CEL - Human Genome and Stem Cell Research Center
Grantee:Mayana Zatz
Support type: Research Grants - Research, Innovation and Dissemination Centers - RIDC